Anavex Life Sciences Corp(NASDAQ:AVXL) 
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Pha...
Website: http://www.anavex.com
Founded: 2004
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 8.02
H 8.39
L 7.79
C 8.19
V 1,482,734
10EMA 8.19
20EMA 8.19
60EMA 8.19
120EMA 8.19
250EMA 8.19